BioTuesdays

Tag - ARTL

Artelo Biosciences Logo
Markets

Maxim ups Artelo Biosciences PT to $5 from $3

Maxim Group raised its price target for Artelo Biosciences (NASDAQ:ARTL) to $5 from $3, citing rising valuations across the cannabinoid and cannabis space, and as Artelo begins to map out its path forward as a cancer...

February 17, 2021
Artelo Biosciences Logo
Markets

Ladenburg starts Artelo Biosciences at buy; PT $7

Ladenburg Thalmann initiated coverage of Artelo Biosciences (NASDAQ:ARTL) with a “buy” rating and price target of $7. The stock closed at $1.63 on Feb. 11. Artelo is developing first-in-class, proprietary therapeutics...

February 12, 2021
Artelo Biosciences Logo
Markets

Maxim cuts Artelo Biosciences to hold and removes PT

Maxim Group downgraded Artelo Biosciences (NASDAQ:ARTL) to “hold” from “ buy” without a price target, citing capital concerns. The stock closed at $1.22 on May 12, near the low end of its 52-week range of 61 cents to...

May 13, 2020